Luke O’Neill is Professor of Biochemistry, Trinity College Dublin, where he leads an 18 member research team working on the molecular basis to inflammation. His lab works on worked on innate immunity, which lies at the heart of inflammation, with a particular interest in Toll-like receptors, inflammasomes and metabolic reprogramming. He is founder director of 2 companies exploring innate immune targeting, Opsona and Inflazome. He is also a member of the External Immunology Network at GSK, where he has been a visiting scientist as part of the Catalyst programme, in 2016.
He was awarded the Royal Dublin Society / Irish Times Boyle Medal for scientific excellence in 2009, the Royal Irish Academy Gold Medal for Life Sciences in 2012 and the European Federation of Immunology Societies Medal in 2014. He was elected a member of EMBO (European Molecular Biology Organisation) in 2005 and a Fellow of the Royal Society in 2016.